当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Open Forum Infectious Diseases杂志
Open Forum Infectious Diseases
基本信息
期刊名称 Open Forum Infectious Diseases
OPEN FORUM INFECT DI
期刊ISSN 2328-8957
期刊官方网站 https://academic.oup.com/ofid
是否OA Yes
出版商 Oxford University Press
出版周期
文章处理费 登录后查看
始发年份
年文章数 603
影响因子 3.8(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 IMMUNOLOGY 免疫学3区
INFECTIOUS DISEASES 传染病学3区
MICROBIOLOGY 微生物学3区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 6.7 1.360 0.935
Medicine
Oncology
106/404 73%
Medicine
Infectious Diseases
96/344 72%
补充信息
自引率 5.3%
H-index 21
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2328-8957%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/OFID
收稿范围
Open Forum Infectious Diseases (OFID) is a fully open-access journal advancing the field of infectious diseases by publishing and promoting high-quality research that improves patient care and public health outcomes. Our goal is to foster collaboration among practitioners, researchers, and policymakers by providing a platform for the exchange of knowledge and ideas. The journal focuses on publishing innovative clinical and translational research, exploring the impact of the natural environment on infectious diseases, enhancing publication literacy among infectious diseases practitioners, and addressing global health challenges. See OFID’s full list of subject sections.

OFID does not publish papers focused on non-infectious-diseases topics unless they are of inherent interest to the infectious diseases community (e.g., medical education papers that aren’t focused on infectious diseases but which have direct applicability to infectious diseases pedagogy). OFID also does not accept phase 1 clinical trials, which may be a better fit for our sister journal, The Journal of Infectious Diseases.

With an Impact Factor of 4.2, the journal is ranked 43 out of 96 journals in the field of infectious diseases.
收录体裁
投稿指南
投稿模板
参考文献格式
编辑信息

Editor-In-Chief

Paul E. Sax, MD is Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital (BWH), and Professor of Medicine at Harvard Medical School. He is Editor-in-Chief of Open Forum Infectious Diseases, is on the Peer Review board of the HIV/AIDS Section of UpToDate, the Editorial Board of NEJM Journal Watch Infectious Diseases (on which he writes the HIV and ID Observations blog), and the editorial advisory board of Medscape HIV/AIDS. In addition to his clinical and teaching work, Dr. Sax’s ongoing areas of research include clinical trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and toxicity of antiretroviral therapy. Dr. Sax also writes the popular blog HIV and ID Observations. Find Dr. Sax on Twitter @PaulSaxMD.


Deputy Editor

Jonathan Z. Li, MD is an Assistant Professor of Medicine in the Division of Infectious Diseases at the Brigham and Women’s Hospital and Harvard Medical School. He is the Director of the Harvard Virology Specialty Laboratory of the AIDS Clinical Trials Group and the Associate Director of the Harvard University Center for AIDS Research Clinical Core. Dr. Li is the chair of two clinical studies in the AIDS Clinical Trials Group and is the principal investigator of a translational virology laboratory. His research focus is in viral persistence, reservoirs, and drug resistance.

 


Associate Editors

John W. Baddley, MD, MSPH is a Professor of Medicine in the Division of Infectious Diseases at the University of Alabama at Birmingham (UAB). He serves as Director, Transplant Infectious Diseases at UAB and Director of the Infection Control Program at the Birmingham VA Medical Center. His clinical work focuses on management of infections in the immunocompromised host. In addition to his clinical and teaching work, Dr. Baddley's ongoing areas of research include clinical trials of antifungal and CMV therapies, epidemiology of fungal infections and safety of biological therapies. Find Dr. Baddley on Twitter @jobadd

 


Jose Castillo-Mancilla: A native from Mexico City, Dr. Jose R. Castillo-Mancilla is an Associate Professor of Medicine in the Division of Infectious Diseases at The University of Colorado School of Medicine. He is a clinical researcher in HIV –with a specific emphasis in clinical pharmacology and antiretroviral adherence– and his research is funded by the National Institutes of Health. He is an investigator within the AIDS Clinical Trials Group where he chairs the Underrepresented Populations Committee and a co-chairs a large multicenter clinical trial focused on novel therapeutic strategies for persons living with HIV who face barriers to adherence. In addition to his research activities, Dr. Castillo-Mancilla serves as a co-Director of the pre K Grant Review Program at the Colorado Clinical and Translational Sciences Institute and provides HIV Primary Care and General Infectious Disease consultation at the University of Colorado Hospital.

 


daily


Johanna P Daily, MD, MS is a Professor of in the Departments of Medicine in the Division of Infectious Diseases and Microbiology and Immunology at Albert Einstein College of Medicine. She carries out translational research on host pathogen biology during natural Plasmodium falciparum infections to understand the mechanisms of disease in cerebral malaria and the development of clinical immunity. She provides general infectious disease care at Montefiore Medical Center.

 


Donald Forthal, MD is a Professor of Medicine and of Molecular Biology and Biochemistry at the University of California, Irvine, where he is also the chief of the Division of Infectious Diseases. His research is primarily focused on understanding how antibodies bound to pathogens or to infected cells interact with host cells bearing Fc receptors. Such interactions are a critical component of how antibodies function either to prevent and control infections or to enhance pathogenesis. As a former Epidemic Intelligence Service officer with the Centers for Disease Control, Dr. Forthal maintains an interest in the epidemiology of viral infections. He has clinical interests in HIV and tropical infections.

 


Inge Gyssens, MD PhD is internist and Professor of Infectious Diseases at Hasselt University, Belgium and senior researcher at Radboud University Medical Center, Nijmegen, The Netherlands. Her research interests focus on optimizing antimicrobial therapy and host-pathogen interaction. She has conducted epidemiological, pre-clinical and clinical research spanning a wide area of Infectious Diseases. She supports audits and intervention studies in Antimicrobial stewardship both in high- and low-resource countries. She has authored over 150 peer-reviewed articles and 15 book chapters. She is presently involved in a EU Horizon 2020 funded project on rapid molecular diagnostics, the FAPIC study. She serves as expert for WHO, EMA and ECDC. She is also Associate editor for Clinical Microbiology & Infection and Frontiers in Medicine.



Kimberly Hanson, MD, MHS is an Associate Professor of Medicine and Pathology at the University of Utah School of Medicine. She has specialized expertise in the diagnosis and management of opportunistic viral, fungal and mycobacterial diseases. Her clinical and research interests focus on the diagnosis and management of infectious complications of transplantation and cancer care. She is board certified in infectious disease, medical microbiology, and general internal medicine.



Keith S. Kaye, MD, MPH is a Professor of Medicine in the Division of Infectious Diseases and Department of Medicine at University of Michigan Medical School. He is the Director of Clinical Research in the Division of Infectious Diseases. Dr. Kaye’s particular academic interests and skills are epidemiology, management and outcomes associated with multi-drug resistant bacteria; antimicrobial stewardship; infections in the elderly; surgical site infection; and device-related infections. Dr. Kaye received his medical degree from the University of Pennsylvania and served his Internal Medicine residency and was an Infectious Diseases fellow at Beth Israel Deaconess Medical Center in Boston, MA. During fellowship, Dr. Kaye earned a Masters in Public Health from the Harvard School of Public Health. Dr. Kaye has authored over 200 peer-reviewed articles and 18 book chapters and has presented numerous abstracts at national conferences. Dr. Kaye has dedicated his entire career to infection prevention and antimicrobial stewardship and is recognized as an international leader expert in these disciplines. He currently is the PI on 2 NIH-funded trials evaluating the treatment of infections due to extremely-drug resistant (XDR) Gram-negative bacteria. Dr. Kaye has been an IDSA member and SHEA member for more than 15 years and is currently President-elect for SHEA.



Maunank Shah, MD, PhD is an Associate Professor in the Division of Infectious Diseases, at Johns Hopkins University where he also co-directs the medical student course on microbiology and infectious diseases at Johns Hopkins School of Medicine. Maunank additionally serves as medical director for the Baltimore City Health Department TB program, serves as a clinical consultant for the CDC-Regional TB Training and Medical Consultation Center, and conducts TB educational activities through the Johns Hopkins Center for Clinical Global Health Education. Previously he has led studies to evaluate the performance and implementation of novel TB diagnostic tools in resource-limited settings. His continuing multi-disciplinary research efforts focus on development of decision-analytic and mathematical models to evaluate the epidemiologic and economic impact of HIV and TB interventions, and on evaluation of new mHealth tools to improve care(such as video-based directly-observed-therapy for TB and other diseases).


Andrej Spec, MD, MSCI is an Assistant Professor in the Division of Infectious Disease at Washington University in St Louis, Missouri, where he also serves as the Associate Director of the Infectious Disease Clinical Research Unt and leads both the Invasive Mycoses Clinic as well as the Washington University Mycoses Group. He is the lead author of "Comprehensive Review of Infectious Disease." His clinical work focuses on invasive mycoses, especially in immunocompromised patients, such as patients with a transplant or congenital immunodeficiency. He does clinical and translational research in Candida spp., Cryptococcus spp. and Histoplasma capsulatum, and he is an active participant in antifungal development through his engagement with the Mycoses Study Group Education and Research Consortium. Find Dr. Spec on Twitter @FungalDoc


Statistical Editor

Katie Mollan, MS

University of North Carolina


Editorial Advisory Board

Jose R. Arribas, MD

Hospital La Paz, Madrid, Spain


Jason P. Burnham, MD

Washington University School of Medicine in St. Louis


Angela Caliendo, MD, FIDSA

Brown University


Daniel Diekema, MD, FIDSA

University of Iowa


Elizabeth Doby, MD

University of Utah


Jeannette Guarner, MD

Emory University


Kayoko Hayakawa, MD, PhD

Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan


Jennifer Horan, MD, PharmD

Duke University Medical Center


Vivek Jain, MD

University of North Carolina


Robin L. P. Jump, MD, PhD

Case Western Reserve University


Brian Kendall, MD

University of Utah


Bernard Macatangay, MD

University of Pittsburgh


Monica V. Mahoney, PharmD, BCPS AQ-ID, BCIDP

Beth Israel Deaconess Medical Center


Patrick Mallon, PhD

University College Dublin School of Medicine and Medical Science, Dublin, Ireland


Dror Marchaim, MD

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel


Emily Toth Martin, PhD

University of Michigan School of Public Health


Michael Mugavero, MD

University of Alabama at Birmingham


Marguerite Neill, MD, FIDSA

Brown University


Thomas Patterson, MD, FIDSA

University of Texas Health Science Center at San Antonio


Federico Perez,  MD MS

VA Northeast Ohio Healthcare System and Case Western Reserve University, Cleveland, Ohio


Cathy Petti, MD

University of South Florida


Jason M. Pogue, PharmD, BCPS-ID

Detroit Medical Center


Jesús Rodríguez-Baño, MD, PhD

Universidad de Sevilla, Spain


Michael Satlin, MD

Weill Cornell Medicine


Brian Schwartz, MD

University of California, San Francisco


Irini Sereti, MD

National Institutes of Health


David L. Thomas, MD, FIDSA

Johns Hopkins University


Joseph Tucker, MD, PhD

University of North Carolina


David L. Wyles, MD

University of California, San Diego

St. Luke’s Roosevelt Hospital Center


OFID Podcast Producer

Meredith Mazzotta


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug